Request Demo
Last update 25 Jun 2025
Human fibrinogen (Yuanda Shuyang)
Last update 25 Jun 2025
Overview
Basic Info
Drug Type Non-recombinant coagulation factor |
Synonyms 蜀阳茵源 |
Target |
Action stimulants |
Mechanism Fibrinogen stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (03 Nov 2021), |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Human fibrinogen (Yuanda Shuyang)CTR20244116
评价人纤维蛋白原治疗慢性肝病患者获得性低纤维蛋白原血症的有效性和安全性的随机、双盲、阳性药平行对照、非劣效、多中心临床试验
[Translation] A randomized, double-blind, active-drug parallel-controlled, non-inferiority, multicenter clinical trial to evaluate the efficacy and safety of human fibrinogen in the treatment of acquired hypofibrinogenemia in patients with chronic liver disease
CTR20240180
评价人纤维蛋白原在先天性纤维蛋白原缺乏症患者中的药代动力学特征，以及治疗出血事件的安全性和有效性的单臂、开放、多中心临床试验
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the pharmacokinetic characteristics of human fibrinogen in patients with congenital fibrinogen deficiency, as well as the safety and efficacy of human fibrinogen in the treatment of bleeding events
CTR20160472
人纤维蛋白原治疗先天性纤维蛋白原减少或缺乏症的疗效及安全性的多中心临床研究
[Translation] A multicenter clinical study on the efficacy and safety of human fibrinogen in the treatment of congenital fibrinogen deficiency or deficiency
100 Clinical Results associated with Human fibrinogen (Yuanda Shuyang)
Login to view more data
100 Translational Medicine associated with Human fibrinogen (Yuanda Shuyang)
Login to view more data
100 Patents (Medical) associated with Human fibrinogen (Yuanda Shuyang)
Login to view more data
100 Deals associated with Human fibrinogen (Yuanda Shuyang)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Afibrinogenemia | China | 03 Nov 2021 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acquired fibrinogen deficiency | Phase 3 | China | 21 Apr 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free